Related Experiment Video
Updated: Apr 15, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Dengue haemorrhagic fever or dengue shock syndrome in children
1Section of Infectious Diseases, Departments of Medicine and Clinical Epidemiology College of Medicine, University of the Philippines, Manila, The Philippines.
Insights
This systematic review evaluates supportive treatments for dengue hemorrhagic fever and dengue shock syndrome in children. Evidence on blood component transfusion, corticosteroids, intravenous immunoglobulin, and fluid types is presented.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Dengue hemorrhagic fever and dengue shock syndrome are significant causes of pediatric hospital admissions and mortality.
- Effective supportive care is crucial for managing severe dengue cases in children.
Purpose of the Study:
- To systematically review the effects of various supportive treatments for dengue hemorrhagic fever or dengue shock syndrome in children.
- To evaluate the effectiveness and safety of specific interventions used in pediatric severe dengue management.
Main Methods:
- Systematic review of medical literature including Medline, Embase, and The Cochrane Library up to March 2014.
- Inclusion of nine studies meeting predefined criteria for pediatric dengue supportive care.
- GRADE evaluation of the quality of evidence for assessed interventions.
Main Results:
- Nine studies were included in the systematic review.
- GRADE methodology was used to assess the quality of evidence for interventions.
- Information on effectiveness and safety of specific treatments was compiled.
Conclusions:
- The review synthesizes evidence on blood component transfusion, corticosteroids, intravenous immunoglobulin, and fluid resuscitation (crystalloids vs. colloids) for severe dengue in children.
- Findings provide insights into the effectiveness and safety profiles of these supportive measures.
- This systematic review aids in clinical decision-making for managing pediatric dengue hemorrhagic fever and dengue shock syndrome.
Introduction:
Dengue haemorrhagic fever and dengue shock syndrome are major causes of hospital admission and mortality in children.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical question: What are the effects of supportive treatments for dengue haemorrhagic fever or dengue shock syndrome in children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2014 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found nine studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: adding blood component transfusion to standard intravenous fluids; adding corticosteroids or intravenous immunoglobulin to standard intravenous fluids; and crystalloids versus colloids.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cholera
Diphtheria
Arboviral Encephalitis
Drug Dosing: Infants and Children
Rheumatic Heart Disease I: Introduction

